| Cat. No. |
Product Name |
CAS No. |
Information |
| PC-60434 |
MW-150
|
1628502-91-9 |
MW-150 (MW01-18-150 SRM) is a novel potent, selective, CNS penetrant and orally active inhibitor of p38α MAPK with Ki of 101 nM. |
| PC-42491 |
SB 203580
|
152121-47-6 |
SB 203580 (Adezmapimod, RWJ 64809) is a specific p38 MAPK inhibitor with IC50 of 0.6 uM. |
| PC-42564 |
Losmapimod
|
585543-15-3 |
Losmapimod (GSK-AHAB, GW856553X, SB856553) is a selective, potent, orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively. |
| PC-42512 |
SB 202190
|
152121-30-7 |
SB 202190 (SB202190, SB-202190) is a potent inhibitor p38α and p38β with IC50 of 50 nM and 100 nM respectively. |
| PC-42526 |
VX-745
|
209410-46-8 |
A potent and selective p38α kinase inhibitor with IC50 of 9 nM. |
| PC-73415 |
Emprumapimod
|
765914-60-1 |
Emprumapimod (PF-07265803, ARRY-371797, ARRY-797) is a potent, selective and orally bioavailable inhibitor of p38α MAPK, inhibits LPS-induced IL-6 production in RPMI-8226 cells with IC50 of 0.1 nM. |
| PC-72610 |
ARRY-371797
|
1036404-17-7 |
ARRY-371797 (ARRY371797) is a potent, selective, oral p38α inhibitor with IC50 of <5 nM, directly inhibits LPS-induced IL-6 production from RPMI-8226 with IC50 of 0.1 nM. |
